申请人:Ye Xiang-Yang
公开号:US20080234249A1
公开(公告)日:2008-09-25
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:
enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.